DexCom Q2 FY26 GAAP net income rises 39% to $249.1 million; revenue climbs 13% to $1.31 billion
DXCM•Non-GAAP results and outlook
Non-GAAP operating income increased to $328.3 million, taking non-GAAP operating margin to 25.1% from 19.2%.
DexCom raised 2026 revenue guidance to $5.18 billion to $5.25 billion.
The company also highlighted positive CONNECT trial results and a reimagined Stelo app with AI-driven insights.
Q2 revenue and profitability rise
DexCom posted Q2 revenue of $1.31 billion, up 13% year over year, with U.S. revenue up 11% and international revenue up 19%.
GAAP operating income climbed to $318.3 million, lifting operating margin to 24.3% from 18.4% a year earlier.
GAAP net income rose to $249.1 million, or $0.64 per diluted share.
